Community Health Network (CHNw) observed higher than national rates of maternal substance use disorder, with a higher number of pregnant women having positive drug screens for opioids, cocaine, amphetamines, barbiturates, and benzodiazepines. It developed a care coordination and substance use program to help reduce the incidence of substance use disorders among pregnant women. Using its data platform and analytics applications, CHNw was able to evaluate the impact of various process measures on patient outcomes.
- $764K in savings by reducing the variable cost per case across the CHNw system over two years, and a 39.9 percent relative reduction in neonatal length of stay (LOS).
- Babies whose mothers took buprenorphine had a 25 percent lower incidence of neonatal abstinence syndrome (NAS) than babies whose mothers took methadone and spent 15.5 fewer days in the hospital.
- 20 percent more patients on buprenorphine tested negative for opiates at the time of delivery than the patients taking methadone.